CN117045724A - 一种视力提升调理中药膏及其制备方法 - Google Patents
一种视力提升调理中药膏及其制备方法 Download PDFInfo
- Publication number
- CN117045724A CN117045724A CN202311221239.7A CN202311221239A CN117045724A CN 117045724 A CN117045724 A CN 117045724A CN 202311221239 A CN202311221239 A CN 202311221239A CN 117045724 A CN117045724 A CN 117045724A
- Authority
- CN
- China
- Prior art keywords
- ointment
- vision
- traditional chinese
- medicinal
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 33
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 230000004438 eyesight Effects 0.000 claims abstract description 36
- 239000003814 drug Substances 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 23
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 16
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229940041616 menthol Drugs 0.000 claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940116229 borneol Drugs 0.000 claims abstract description 14
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 14
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940099259 vaseline Drugs 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 8
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 8
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 8
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 8
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 8
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 8
- 240000000249 Morus alba Species 0.000 claims abstract description 8
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 241001146210 Senecio scandens Species 0.000 claims abstract description 8
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 4
- 235000005412 red sage Nutrition 0.000 claims abstract description 4
- 241001113925 Buddleja Species 0.000 claims abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 12
- 239000006260 foam Substances 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 241000123846 Buddleja officinalis Species 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000008719 thickening Effects 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 5
- 230000006872 improvement Effects 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 230000004377 improving vision Effects 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 238000010926 purge Methods 0.000 abstract description 2
- 230000004379 myopia Effects 0.000 description 13
- 208000001491 myopia Diseases 0.000 description 13
- 208000003464 asthenopia Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 238000003825 pressing Methods 0.000 description 9
- 208000006550 Mydriasis Diseases 0.000 description 7
- 241000208340 Araliaceae Species 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 4
- 239000011521 glass Substances 0.000 description 3
- 208000010415 Low Vision Diseases 0.000 description 2
- 241001272720 Medialuna californiensis Species 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 208000027932 Collagen disease Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 201000002287 Keratoconus Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002911 mydriatic effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种视力提升调理中药膏及其制备方法,中药膏包含以下重量百分比原料:千里光12‑18%、决明子加入量5‑8%、桑叶5‑10%、女贞子0.5‑1.5%、枸杞1‑2%、野菊花4‑8%、密蒙花2‑5%、青箱子3‑6%、丹参3‑5%、人参1‑3%、薄荷脑1‑2.5%、冰片2‑4%、甘油12‑18%、凡士林28‑35%。中药膏由多种中药材组合协同,主要用于清肝明目,活血通络,泻火散热,配合眼部穴位按摩,对帮助视力提升有显著的效果。可以让视力下降的人员更有效的提升视力。纯中药膏剂配合按摩手法对身体没有任何副作用,相对于其他视力提升方式有明显的优势。
Description
技术领域
本发明涉及中药膏技术领域,具体为一种视力提升调理中药膏及其制备方法。
背景技术
生活在信息社会里,电脑、电视机、游戏机等视屏显示终端已渗透到人们日常生活的每个部分,尤其是每天使用电脑的上班族,已经成为视觉疲劳的主要人群,长时间面对电脑荧光屏,而又保持固定操作姿势,是导致上班族视觉疲劳的主要原因之一。
近视眼手术治疗,手术治疗适应的症状为:年龄满18岁以上;近视屈光度2.50D或以上,戴镜矫正视力正常,角膜无活动性病变或圆锥角膜,无糖尿病史或胶原性疾病,近视眼手术在一定程度上解决了近视的戴镜问题,也满足了从事特殊职业的人工作的需要,受到了近视眼病人的欢迎,但是,手术无论多么的简单、安全,也绝非万无一失。
也有一部分患者采用眼睛训练仪、手法按摩或艾灸进行视力调理,这些方法存在处理效果表面、调理效果不佳、时效短的缺陷。
发明内容
本发明的目的在于提供一种视力提升调理中药膏及其制备方法。
为实现上述目的,本发明提供如下技术方案:一种视力提升调理中药膏包含以下重量百分比原料:千里光12-18%、决明子加入量5-8%、桑叶5-10%、女贞子0.5-1.5%、枸杞1-2%、野菊花4-8%、密蒙花2-5%、青箱子3-6%、丹参3-5%、人参1-3%、薄荷脑1-2.5%、冰片2-4%、甘油12-18%、凡士林28-35%。
优选的,所述的视力提升调理中药膏包含以下重量百分比原料:千里光15%、决明子加入量6.0%、桑叶8.5%、女贞子1.0%、枸杞1.5%、野菊花6%、密蒙花3%、青箱子4.8%、丹参4%、人参1.2%、薄荷脑1.5%、冰片2.5%、甘油15%、凡士林30%。
一种视力提升调理中药膏的制备工艺为:步骤一:将中药膏的原料配方进行配料、辅料配齐,分别放置;
步骤二、把中药原料放入消毒后的容器内,加入适量的水,让中药吸收水分膨胀,再加水以高出药面10厘米左右,浸泡24小时;
步骤三、第一煎,将药草煎煮6小时以上至浓稠,过滤出头道药汁;
第二煎,加清水把原来的药渣放入后继续煎煮4小时以上,过滤出第二道药汁;
第三煎,煎法同前步骤二,煎煮时间2小时以上,滤净药汁后将药渣倒弃;
将前三煎所得药汁混合一处,静置沉淀后过滤;
步骤四、把过滤过的药汁倒入锅中用大火煎熬,加速水分蒸发,去浮沫,中药变稠厚,用小火进一步浓缩,并不断搅拌;
步骤五、把甘油和凡士林用玻璃器皿加热至80℃至融化;
步骤六、把冰片和薄荷脑研沫后加入至溶解;
步骤七、在煎好的药液中依次倒入甘油、凡士林溶液、冰片沫,薄荷脑沫并不断搅拌20-30分钟,直至能扯拉成旗样即可;
步骤八、将做好的药膏装入清洁干净的容器内快速进行分装。
与现有技术相比,本发明的有益效果如下:中药膏由多种中药材组合协同,主要用于清肝明目,活血通络,泻火散热,配合眼部穴位按摩,对帮助视力提升有显著的效果。可以让视力下降的人员更有效的提升视力。纯中药膏剂配合中医按摩手法对身体没有任何副作用,相对于其他视力提升方式有明显的优势。
附图说明:
图1为本发明的制备流程图。
具体实施方式
下面将结合本发明实施例中对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种视力提升调理中药膏包含以下重量百分比原料:千里光15%、决明子加入量6.0%、桑叶8.5%、女贞子1.0%、枸杞1.5%、野菊花6%、密蒙花3%、青箱子4.8%、丹参4%、人参1.2%、薄荷脑1.5%、冰片2.5%、甘油15%、凡士林30%。
实施例2
一种视力提升调理中药膏包含以下重量百分比原料:千里光14%、决明子加入量7.0%、桑叶9.5%、女贞子1.0%、枸杞1.5%、野菊花5%、密蒙花3%、青箱子4.8%、丹参4%、人参1.2%、薄荷脑1.8%、冰片2.2%、甘油18%、凡士林27%。
实施例3
一种视力提升调理中药膏包含以下重量百分比原料:千里光16%、决明子加入量5.0%、桑叶9.5%、女贞子1.0%、枸杞1.5%、野菊花5%、密蒙花4%、青箱子3.8%、丹参5%、人参1.0%、薄荷脑1.7%、冰片2.5%、甘油14%、凡士林30%。
实施例1-3的一种视力提升调理中药膏的制备工艺包含以下步骤:步骤一:将中药膏的原料配方进行配料、辅料配齐,分别放置;
步骤二、把中药原料放入消毒后的容器内,加入适量的水,让中药吸收水分膨胀,再加水以高出药面10厘米左右,浸泡24小时;
步骤三、第一煎,将药草煎煮6至浓稠,过滤出头道药汁;
第二煎,加清水把原来的药渣放入后继续煎煮4小时,过滤出第二道药汁;
第三煎,煎法同前步骤二,煎煮时间2小时,滤净药汁后将药渣倒弃;
将前三煎所得药汁混合一处,静置沉淀后过滤;
步骤四、把过滤过的药汁倒入锅中用大火煎熬,加速水分蒸发,去浮沫,中药变稠厚,用小火进一步浓缩,并不断搅拌;
步骤五、把甘油和凡士林用玻璃器皿加热至80℃至融化;
步骤六、把冰片和薄荷脑研沫后加入至溶解;
步骤七、在煎好的药液中依次倒入甘油、凡士林溶液、冰片沫,薄荷脑沫并不断搅拌25分钟,直至能扯拉成旗样即可;
步骤八、将做好的药膏装入清洁干净的容器内快速进行分装。
将实施例1-3制备的药膏对600名视力下降的人员的视力提升效果进行观察、记录,其中均为15岁以下的青少年。具体治疗效果如下表所示:
表1
由此可验证本实施例对于视力提升具有较好的疗效。
具体案例:
案例1:患者:张某某,女性,12岁,近视度数:100度
病情:学习任务繁重,长期用眼过度,导致视力逐渐下降。
治疗过程:神瞳中医眼科医院采用中医理论,根据小张的体质特点,制定了个性化的治疗方案。包括徒手点穴、推拿、中药外用等综合治疗方法。经过一个月的治疗,小张的近视度数恢复至1.5。
案例2:患者:李某某,男性,15岁,近视度数:450度
病情:长时间面对电脑屏幕,导致眼睛疲劳、干涩,近视度数逐渐加深。
治疗过程:根据小李的情况,神瞳中医眼科采用中药外用和徒手点穴的方法进行治疗。经过三个月的治疗,小李的眼睛疲劳和干涩症状得到明显缓解,近视度数恢复至1.2。
案例3:患者:王某,女性,16岁,近视度数:600度
病情:网课期间长时间面对手机屏幕使得眼睛疲劳、视力下降,影响日常生活和学习。
治疗过程:神瞳中医眼科采用徒手点穴配合中药治疗的方法,缓解小王的眼睛疲劳和改善视力。治疗过程中,患者积极配合,经过四个月的治疗,近视度数得到有效提升,视力恢复至1.2。
案例4:患者:周某某,男性,17岁,近视度数:700度
病情:高度近视导致眼睛疲劳、眩晕,影响学习和生活。
治疗过程:神瞳中医眼科根据小周的体质特点,采用徒手点穴、推拿和中药外用治疗相结合的方法。经过五个月的治疗,小周的眼睛疲劳和眩晕症状消除,视力恢复至1.2。
案例5:患者:丁某某,女性,18岁,近视度数:500度
病情:长期佩戴隐形眼镜导致眼睛干涩、疲劳,甚至出现眼部炎症,导致近视度数加重。
治疗过程:神瞳中医眼科医院采用中药外用和徒手点穴相结合的方法,以缓解小丁的眼睛不适。经过三个月的治疗,小丁的眼睛干涩和疲劳症状消除,近视度数恢复至1.2。
案例6:患者:刘某,男性,41岁,近视度数:700度
病情:工作生活压力大,长时间面对电脑屏幕,导致眼睛疲劳、视力下降。
治疗过程:神瞳中医眼科医院采用徒手点穴和推中药外用结合的方法,以缓解小刘的眼睛疲劳。经过六个疗程的治疗,小刘的视力得到明显提高,近视度数恢复至1.0。
案例7:患者:马某某,女性,7岁,近视度数:200度
病情:长时间看手机和电视眼睛视力下降,导致注意力不集中影响学习。
治疗过程:神瞳中医眼科医院采用中药外用和徒手点穴的方法进行治疗。经过一个半月的治疗,小马的眼睛视力明显提高,已经恢复至1.5。
案例8:患者:金某,男性,8岁,近视度数:300度
病情:玩手机和网课导致眼睛疲劳、视力下降。
治疗过程:神瞳中医眼科采用徒手点穴和中药外用相结合的方法进行治疗。经过二个月的治疗,小金的眼睛疲劳得到明显缓解,近视度数恢复至1.2。
案例9:患者:金某,女性,8岁,近视度数:200度
病情:玩手机和上网课导致视力下降。
治疗过程:神瞳中医眼科医院采用中药外用和徒手点穴相结合的方法进行治疗。经过一个半月的治疗,小金的眼睛视力得到明显提升,视力恢复至1.5。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (3)
1.一种视力提升调理中药膏,其特征在于:所述的中药膏包含以下重量百分比原料:千里光12-18%、决明子加入量5-8%、桑叶5-10%、女贞子0.5-1.5%、枸杞1-2%、野菊花4-8%、密蒙花2-5%、青箱子3-6%、丹参3-5%、人参1-3%、薄荷脑1-2.5%、冰片2-4%、甘油12-18%、凡士林28-35%。
2.根据权利要求1所述的一种视力提升调理中药膏,其特征在于:所述的视力提升调理中药膏包含以下重量百分比原料:千里光15%、决明子加入量6.0%、桑叶8.5%、女贞子1.0%、枸杞1.5%、野菊花6%、密蒙花3%、青箱子4.8%、丹参4%、人参1.2%、薄荷脑1.5%、冰片2.5%、甘油15%、凡士林30%。
3.一种视力提升调理中药膏的制备工艺,其特征在于为:具体工艺为:
步骤一:将中药膏的原料配方进行配料、辅料配齐,分别放置;
步骤二、把中药原料放入消毒后的容器内,加入适量的水,让中药吸收水分膨胀,再加水以高出药面10厘米左右,浸泡24小时;
步骤三、第一煎,将药草煎煮6小时以上至浓稠,过滤出头道药汁;
第二煎,加清水把原来的药渣放入后继续煎煮4小时以上,过滤出第二道药汁;
第三煎,煎法同前步骤二,煎煮时间2小时以上,滤净药汁后将药渣倒弃;
将前三煎所得药汁混合一处,静置沉淀后过滤;
步骤四、把过滤过的药汁倒入锅中用大火煎熬,加速水分蒸发,去浮沫,中药变稠厚,用小火进一步浓缩,并不断搅拌;
步骤五、把甘油和凡士林用玻璃器皿加热至80℃至融化;
步骤六、把冰片和薄荷脑研沫后加入至溶解;
步骤七、在煎好的药液中依次倒入甘油、凡士林溶液、冰片沫,薄荷脑沫并不断搅拌20-30分钟,直至能扯拉成旗样即可;
步骤八、将做好的药膏装入清洁干净的容器内快速进行分装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311221239.7A CN117045724A (zh) | 2023-09-20 | 2023-09-20 | 一种视力提升调理中药膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311221239.7A CN117045724A (zh) | 2023-09-20 | 2023-09-20 | 一种视力提升调理中药膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117045724A true CN117045724A (zh) | 2023-11-14 |
Family
ID=88666498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311221239.7A Pending CN117045724A (zh) | 2023-09-20 | 2023-09-20 | 一种视力提升调理中药膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117045724A (zh) |
-
2023
- 2023-09-20 CN CN202311221239.7A patent/CN117045724A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102188604A (zh) | 一种治疗近视、老花眼的药物 | |
CN109620909A (zh) | 中药组合物、中药眼膜及其制备和使用方法 | |
CN104383168B (zh) | 一种提高视力的中药药膏及其制备方法 | |
CN109876050A (zh) | 复方黄芪液 | |
CN106388996A (zh) | 一种预防近视的眼部护理装置 | |
CN104524038A (zh) | 一种预防和治疗近视的中药组合物及其用法 | |
CN102370830B (zh) | 清眼按摩中药制剂及其制备方法 | |
CN117045724A (zh) | 一种视力提升调理中药膏及其制备方法 | |
CN114010591B (zh) | 一种视疲劳治疗的外用中药凝胶膏及其制备方法 | |
CN107260512B (zh) | 中医眼部理疗仪 | |
CN1263485C (zh) | 五子明目丸及其制备工艺 | |
CN111329915B (zh) | 一种用于缓解老年人视疲劳的组合物及其亲水凝胶 | |
CN100574787C (zh) | 一种内服治疗青光眼的中药组合物 | |
CN103340992A (zh) | 一种调整视力的眼帖膏 | |
CN112107650A (zh) | 一种缓解视疲劳的眼膏及其制备方法、走珠眼膏 | |
CN113018337A (zh) | 一种治疗眼疾的复方及其制备方法与应用 | |
CN110585356A (zh) | 一种用于改善青少年视力的中药配方及使用方法 | |
CN110302357A (zh) | 一种外用明目保健中药组合物及其制备方法 | |
CN110624086A (zh) | 一种有助于改善视力的中药组合物及其制备方法 | |
CN109223919A (zh) | 一种石墨烯瑶药护眼罩及其制备方法 | |
CN110327433B (zh) | 一种使眼角上扬、眼部放松的液体制剂 | |
CN113274427A (zh) | 一种具有近视防控功能的护眼贴 | |
CN107753839B (zh) | 中药组合物及其应用、包含该中药组合物的中药贴膏及其制备和使用方法 | |
CN113546144A (zh) | 一种治疗近视眼的中药组合物其制备方法 | |
CN105796749A (zh) | 一种缓解视疲劳的穴位按摩及中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |